Current Report Filing (8-k)
November 08 2018 - 5:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 8, 2018
CONMED CORPORATION
(Exact name of registrant as specified in its
charter)
New York
|
0-16093
|
16-0977505
|
(State or other jurisdiction of
|
(Commission
|
(I.R.S. Employer
|
incorporation or organization)
|
File Number)
|
Identification No.)
|
525 French Road
Utica, New York 13502
(Address of principal executive offices, including
zip code)
(315) 797-8375
(Registrant's telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction
A.2 below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
o
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 8.01 Other Events
On November 8, 2018, CONMED Corporation announced
it will be paying a quarterly cash dividend of $0.20 per share on January 7, 2019 to all shareholders of record as of December
14, 2018.
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
CONMED CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
|
|
By:
|
|
/s/ Todd W. Garner
|
Name:
|
|
Todd W. Garner
|
Title:
|
|
Executive Vice President and
Chief Financial Officer
|
Date: November 8, 2018
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Oct 2023 to Oct 2024